Kalaris Therapeutics Inc (KLRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KLRS | SGMT | ELTX | ||
| Company | Kalaris Therapeutics Inc | Sagimet Biosciences Inc Series A | Elicio Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.56 | 6.14 | 11.00 | ||
| High | 10.63 | 6.17 | 11.25 | ||
| Low | 10.35 | 5.83 | 10.50 | ||
| Latest | 10.35 | 5.82 | 11.14 | ||
| Change | -0.28 | -0.31 | +0.16 | ||
| % Change | -2.63% | -5.06% | +1.46% | ||
| Volume | 5,402 | 137,769 | 59,553 | ||
| 20-Day Average Volume | 61,895 | 827,932 | 140,971 | ||
| Previous Close | 10.63 | 6.13 | 10.98 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.52 | 5.59 | 8.78 | ||
| 20-Day Raw Stochastic | 72.41% | 41.67% | 99.48% | ||
| 20-Day Relative Strength | 55.74 | 50.53 | 70.09 | ||
| Weighted Alpha | +29.02 | -0.70 | +34.66 | ||
| Today's Opinion | 100% Buy | 64% Sell | 8% Buy | ||
| Previous Opinion | 100% Buy | 64% Sell | 8% Buy | ||
| Last Month's Opinion | 100% Buy | 64% Sell | 48% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.74% since 02/19/26 | +9.11% since 02/19/26 | +26.75% since 02/19/26 | ||
| Low | 9.81 on 02/23/26 | 5.12 on 02/23/26 | 8.61 on 02/23/26 | ||
| High | 11.22 on 02/24/26 | 6.25 on 02/25/26 | 11.25 on 02/26/26 | ||
| 1-Month | |||||
| %Chg | +5.08% since 01/26/26 | -2.65% since 01/26/26 | +35.96% since 01/26/26 | ||
| Low | 8.08 on 02/17/26 | 4.92 on 02/17/26 | 7.37 on 01/30/26 | ||
| High | 11.22 on 02/24/26 | 7.20 on 02/03/26 | 11.25 on 02/26/26 | ||
| 3-Month | |||||
| %Chg | +60.71% since 11/26/25 | -17.09% since 11/26/25 | +22.60% since 11/26/25 | ||
| Low | 5.10 on 12/02/25 | 4.92 on 02/17/26 | 7.37 on 01/30/26 | ||
| High | 11.88 on 12/18/25 | 7.28 on 11/28/25 | 11.25 on 02/26/26 | ||
| 6-Month | |||||
| %Chg | +304.30% since 08/26/25 | -16.97% since 08/26/25 | +5.94% since 08/26/25 | ||
| Low | 2.55 on 08/27/25 | 4.92 on 02/17/26 | 7.37 on 01/30/26 | ||
| High | 11.88 on 12/18/25 | 9.46 on 10/27/25 | 12.62 on 09/17/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 198,802 | 199,360 | 192,040 | ||
| Shares Outstanding, K | 18,702 | 32,522 | 17,490 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -58,770,000 | -45,570,000 | -51,900,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -11,890,000 | -12,910,000 | -10,080,000 | ||
| 60-Month Beta | -0.09 | 3.39 | 1.19 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.64 on 11/12/25 | -0.40 on 11/13/25 | -0.60 on 11/13/25 | ||
| Latest Earnings Date | 03/06/26 | 03/11/26 | 03/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||